CC
MRK icon

Centiva Capital’s Merck MRK Stock Holding History

Centiva Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$995K – 1925
2024
Q4 		$995K Sell
10,000
-15,000
-60% -$1.55M 0.02% 527
2024
Q3 		$2.84M Buy
25,000
+3,500
+16% +$416K 0.06% 310
2024
Q2 		$2.66M Buy
21,500
+1,500
+8% +$193K 0.05% 285
2024
Q1 		$2.64M Buy
20,000
+13,800
+223% +$1.7M 0.06% 240
2023
Q4 		$676K Sell
6,200
-800
-11% -$83K 0.02% 814
2023
Q3 		$721K Sell
7,000
-3,000
-30% -$323K 0.02% 789
2023
Q2 		$1.15M Sell
10,000
-10,000
-50% -$1.14M 0.03% 531
2023
Q1 		$2.13M Buy
+20,000
New +$2.16M 0.05% 383
2022
Q4 		– Sell
-20,100
Closed -$1.73M – 1533
2022
Q3 		$1.73M Buy
20,100
+10,000
+99% +$893K 0.03% 403
2022
Q2 		$921K Sell
10,100
-900
-8% -$79.8K 0.02% 659
2022
Q1 		$903K Sell
11,000
-33,500
-75% -$2.64M 0.02% 750
2021
Q4 		$3.41M Buy
+44,500
New +$3.54M 0.07% 248
2020
Q3 		– Sell
-105
Closed -$8K – 816
2020
Q2 		$8K Hold
105
– – ﹤0.01% 641
2020
Q1 		$8K Buy
+105
New +$8.25K ﹤0.01% 566
2019
Q4 		– Sell
-2,725
Closed -$219K – 890
2019
Q3 		$219K Hold
2,725
– – 0.01% 495
2019
Q2 		$218K Sell
2,725
-3,144
-54% -$241K 0.01% 334
2019
Q1 		$466K Sell
5,869
-62,985
-91% -$4.71M 0.03% 233
2018
Q4 		$5.02M Buy
68,854
+23,685
+52% +$1.67M 0.4% 39
2018
Q3 		$3.06M Buy
45,169
+2,096
+5% +$134K 0.26% 59
2018
Q2 		$2.5M Buy
+43,073
New +$2.43M 0.53% 16

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's MRK Position: Q2 2026 in Review

Centiva Capital increased its Merck (MRK) stake by 80% in Q2 2026, buying an estimated $281K and bringing the position to 5,405 shares worth $695K. The position accounts for 0.01% of the portfolio, ranked #762.

Centiva Capital first reported a position in MRK in Q3 2019 and has held it in 23 quarters since. The position peaked at $13.9M in Q1 2023. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Centiva Capital held 5,405 shares of Merck worth $695K as of Q2 2026.
  • Centiva Capital bought 2,397 Merck shares in Q2 2026, an estimated $281K.
  • Merck made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #762 holding.
  • Centiva Capital first reported a position in Merck in Q3 2019 and has held it in 23 quarters since.
  • Centiva Capital's Merck position peaked at $13.9M in Q1 2023.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.